ACTR1A

actin related protein 1A, the group of Actin related proteins|Dynactin subunits

Basic information

Region (hg38): 10:102461881-102502712

Links

ENSG00000138107NCBI:10121OMIM:605143HGNC:167Uniprot:P61163AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ACTR1A gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACTR1A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
5
clinvar
5
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 5 0 0

Variants in ACTR1A

This is a list of pathogenic ClinVar variants found in the ACTR1A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-102471284-A-T not specified Uncertain significance (Oct 29, 2021)2258081
10-102471332-G-A not specified Likely benign (Jul 06, 2021)2252850
10-102473825-C-T Likely benign (Dec 01, 2022)2640793
10-102473849-G-C not specified Uncertain significance (Jul 08, 2021)2235455
10-102482002-T-A not specified Uncertain significance (Oct 25, 2022)2319169
10-102482123-A-G not specified Uncertain significance (Mar 12, 2024)3142331
10-102484227-T-C not specified Uncertain significance (Mar 29, 2022)2280111
10-102484230-A-T not specified Uncertain significance (Aug 17, 2022)2308680
10-102484243-G-A not specified Uncertain significance (Mar 21, 2024)3264618
10-102488184-T-C not specified Uncertain significance (Oct 12, 2022)2318595
10-102489138-A-G not specified Likely benign (May 12, 2024)3264628

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ACTR1Aprotein_codingprotein_codingENST00000369905 1123497
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9660.0338125730041257340.0000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.031002290.4370.00001412449
Missense in Polyphen3096.5690.310661034
Synonymous1.607089.20.7850.00000575753
Loss of Function3.94323.70.1260.00000148244

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.00004670.0000462
European (Non-Finnish)0.000008790.00000879
Middle Eastern0.00005440.0000544
South Asian0.00003900.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of a multi-subunit complex involved in microtubule based vesicle motility. It is associated with the centrosome.;
Pathway
Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Regulation of PLK1 Activity at G2/M Transition;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Recruitment of mitotic centrosome proteins and complexes;Loss of Nlp from mitotic centrosomes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;AURKA Activation by TPX2;G2/M Transition;Mitotic G2-G2/M phases;COPI-independent Golgi-to-ER retrograde traffic;Golgi-to-ER retrograde transport;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;COPI-mediated anterograde transport;M Phase;Cell Cycle;ER to Golgi Anterograde Transport;Cell Cycle, Mitotic;Anchoring of the basal body to the plasma membrane;Intra-Golgi and retrograde Golgi-to-ER traffic;Cilium Assembly;Organelle biogenesis and maintenance (Consensus)

Recessive Scores

pRec
0.546

Intolerance Scores

loftool
0.266
rvis_EVS
-0.36
rvis_percentile_EVS
28.63

Haploinsufficiency Scores

pHI
0.304
hipred
Y
hipred_score
0.749
ghis
0.599

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
H
gene_indispensability_pred
E
gene_indispensability_score
0.965

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Actr1a
Phenotype

Gene ontology

Biological process
G2/M transition of mitotic cell cycle;endoplasmic reticulum to Golgi vesicle-mediated transport;spermatogenesis;regulation of G2/M transition of mitotic cell cycle;vesicle-mediated transport;antigen processing and presentation of exogenous peptide antigen via MHC class II;ciliary basal body-plasma membrane docking
Cellular component
manchette;cytoplasm;centrosome;centriole;cytosol;dynactin complex;microtubule associated complex;microtubule cytoskeleton;COPI-coated vesicle;myelin sheath;extracellular exosome;cell cortex region
Molecular function
protein binding;ATP binding